Latest News

B-1 immune cells can recognize all sorts of viruses, Yale researchers find. Mimicking them may enable a pan-virus treatment that can address many virus types.

No other vaccines are given at such a high frequency, but experts say there’s no reason to believe that the vaccines — and in particular, the mRNA vaccines from Pfizer and Moderna — aren’t effective.

An ongoing study by Yale scientists has uncovered another nagging symptom of Long COVID: internal tremors that patients feel but are hard for health providers to detect.

For months, governmental officials around the world have appeared to want to forgo discussing the specter of long COVID. As a new review makes clear, that is wishful thinking—and the latest COVID variants may well kick long COVID into overdrive, a scenario that researchers and experts have been warning about for some time.

Two close relatives of SARS-CoV-2 have reduced transmission potential, a new study finds. Understanding why could help identify future pandemic threats.

This April, Akiko Iwasaki, PhD, Sterling Professor of Immunobiology and Professor of Dermatology and Molecular, Cellular, and Developmental Biology, and of Epidemiology at Yale, was named to the TIME100 by TIME Magazine.

Mice that received antibodies from Long COVID patients showed symptoms including pain and dizziness, a Yale-led study has found.

How has the risk of contracting Long COVID changed over the years, as the virus has evolved and almost everyone in the U.S. has gotten vaccinated, infected, or both (sometimes many times over)?